2025-02-11 Unilumin Group., Ltd. HaiPress
BARCELONA,Spain,Feb. 10,2025 -- AtISE 2025 in Barcelona,Unilumin Group once again demonstrated its industry leadership by winning the prestigious Inavation Awards for its Upanel II MIP. As one of the AV industry's most influential accolades,this award recognizes Unilumin's relentless pursuit of innovation and excellence in LED display technology. The achievement underscores the company's strong R&D capabilities and its commitment to delivering cutting-edge solutions to the global market.

Unilumin Wins Inavation Awards at ISE 2025
Beyond this remarkable win,Unilumin made a powerful statement at ISE 2025 with a showcase of its latest innovations. The company unveiled three new products—Unatural,Udesign SV,and Uslim III O—alongside its Metasight platform and cinema solutions. These innovations attracted significant attention,with visitors experiencing firsthand the future of LED display technology.

Unilumin Shines at ISE 2025
Unilumin's multi-brand presence,featuring Unilumin,LAMPRO,and ROE Visual,ensured comprehensive market coverage,meeting diverse industry needs. To strengthen global partnerships,Unilumin hosted an exclusive Customer Appreciation Dinner,bringing together industry leaders for strategic discussions,a grand signing ceremony,and interactive activities.
With this latest international recognition and a continued commitment to innovation,Unilumin is setting new benchmarks in LED technology,driving the industry forward and empowering businesses worldwide.
Formoreinformation,pleasevisithttps://www.unilumin.com/
Cangxi County Holds 2026 New Year's Cultural Performance for the Public
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement
©copyright 2009-2020 Singapore Info Map